Study author Sun H Kim, MD, MS, Associate Professor of Medicine in the Division of Endocrinology, Gerontology, and Metabolism at Stanford, summarized the findings to to Medical News Today , saying: We found that semaglutide compared to other weight loss medications, including another GLP-1 medication called dulaglutide, reduced risk of future fractures despite being associated with greater weight loss. Overall, semaglutide was linked to a bigger decrease in BMI
Segaglutide, formerly known as Ozempic, has demonstrated efficacy as a weight-management strategy when paired with a balanced diet and physical activity
The prevalence increases with age and can be influenced by factors like menopause, infections, and certain medications
DCI, diabetic cognitive impairment